Compugen Ltd SEC filings CGEN
Compugen Ltd has 607 filings in SEC EDGAR's recent list, going back to Feb 13, 2001. Its latest annual report, Form 20-F, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Aug 4, 2026 | — |
| CORRESP | Letter to the SEC | Jul 28, 2026 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2026 | — |
| EFFECT | Filing | Jun 8, 2026 | — |
| CORRESP | Letter to the SEC | Jun 4, 2026 | — |
| UPLOAD | Letter from the SEC | May 21, 2026 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2023 | — |
| CORRESP | Letter to the SEC | Aug 23, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2023 | — |
| EFFECT | Filing | Jun 27, 2023 | — |
| CORRESP | Letter to the SEC | Jun 23, 2023 | — |
| CORRESP | Letter to the SEC | Apr 14, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2023 | — |
| D | Filing | Nov 22, 2021 | — |
| EFFECT | Filing | Aug 7, 2020 | — |
| CORRESP | Letter to the SEC | Aug 5, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2020 | — |
| EFFECT | Filing | Aug 12, 2019 | — |
| CORRESP | Letter to the SEC | Aug 8, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2019 | — |
| CT ORDER | Filing | May 30, 2019 | — |
| CT ORDER | Filing | Dec 4, 2018 | — |
| D | Filing | Oct 16, 2018 | — |
| CT ORDER | Filing | Sep 4, 2018 | — |
| CT ORDER | Filing | May 18, 2018 | — |
| CT ORDER | Filing | Aug 14, 2017 | — |
| EFFECT | Filing | Oct 11, 2016 | — |
| CORRESP | Letter to the SEC | Oct 6, 2016 | — |
| CORRESP | Letter to the SEC | Oct 6, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 5, 2016 | — |
| CORRESP | Letter to the SEC | Sep 21, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2016 | — |
| CT ORDER | Filing | Aug 25, 2016 | — |
| EFFECT | Filing | Sep 4, 2014 | — |
| CT ORDER | Filing | Jun 11, 2014 | — |
| EFFECT | Filing | Jan 16, 2013 | — |
| CT ORDER | Filing | Feb 3, 2012 | — |
| EFFECT | Filing | Jan 21, 2011 | — |
| CORRESP | Letter to the SEC | Jan 21, 2011 | — |
| CORRESP | Letter to the SEC | Jan 20, 2011 | — |
| CORRESP | Letter to the SEC | Jan 20, 2011 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2011 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2010 | — |
| CORRESP | Letter to the SEC | Sep 22, 2010 | — |
| CORRESP | Letter to the SEC | Sep 22, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2010 | — |
| EFFECT | Filing | Jan 21, 2010 | — |
| EFFECT | Filing | Sep 10, 2009 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2007 | — |
| CORRESP | Letter to the SEC | Jul 30, 2007 | — |
| CORRESP | Letter to the SEC | Jul 11, 2007 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2007 | — |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Holon, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1119774
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.